Compare CYTK & AWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | AWI |
|---|---|---|
| Founded | 1997 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.5B |
| IPO Year | 2004 | 2006 |
| Metric | CYTK | AWI |
|---|---|---|
| Price | $63.24 | $190.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $83.69 | ★ $203.14 |
| AVG Volume (30 Days) | ★ 2.1M | 426.2K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 23.00 |
| EPS | N/A | ★ 6.97 |
| Revenue | $87,211,000.00 | ★ $1,600,200,000.00 |
| Revenue This Year | $339.72 | $14.13 |
| Revenue Next Year | $79.08 | $6.91 |
| P/E Ratio | ★ N/A | $27.01 |
| Revenue Growth | ★ 2609.26 | 15.10 |
| 52 Week Low | $29.31 | $122.37 |
| 52 Week High | $70.98 | $206.08 |
| Indicator | CYTK | AWI |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 46.36 |
| Support Level | $61.10 | $195.03 |
| Resistance Level | $65.35 | $201.92 |
| Average True Range (ATR) | 3.03 | 6.07 |
| MACD | 0.00 | -0.81 |
| Stochastic Oscillator | 58.49 | 16.57 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.